Laurent Tessier, 17, survived a virulent cancer thanks to a genetic research program launched to provide young people with personalized treatments.


At CHU Sainte-Justine in 2012, this precision medicine research program in pediatric oncology (called TRICEPS) was a first in the field.


Daniel Sinnett, a geneticist, and co-director of the TRICEPS program oversaw this treatment within the program and stipulates that many other young people in Quebec have been saved by discovering treatment options tailored to each patient.


This article explains how precision medicine, through genomic profiling, has saved the lives of many young patients, including Laurent Tessier.

To read Laurent Tessier’s story, click here.

To hear the radio interview, click here.